Ziegler et al.78 showed that higher levels of properdin were found in the urine of patients with renal disease vs healthy individuals, and Corvillo et al.79 proposed using serum properdin concentrations as a diagnostic marker for a subset of C3 glomerulopathy patients. This evidence concerns the gene CFP and complement 3 glomerulopathy.